[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649008":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":15,"collaborators":10,"id":19,"slug":20,"hasResults":21,"nctId":22,"briefTitle":23,"officialTitle":24,"acronym":25,"eligibilityCriteria":26,"healthyVolunteers":21,"sex":27,"minAge":28,"maxAge":10,"enrollmentInfo":29,"targetDuration":10,"studyType":32,"phases":10,"briefSummary":33,"conditions":34,"keywords":39,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"Sinai University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Lower Vitamin D Status Group",null,"Participants with obesity and established type 2 diabetes mellitus who have lower serum 25-hydroxyvitamin D \\[25(OH)D\\] concentrations according to the predefined study criteria. Vitamin D deficiency is defined as serum 25(OH)D concentration below 20 ng\u002FmL. Participants in this group will undergo clinical and laboratory assessments, including lipid profile and glycemic measurements, to evaluate metabolic characteristics associated with lower vitamin D status.",{"label":13,"type":10,"description":14,"interventionNames":10},"Higher Vitamin D Status Group","Participants with obesity and established type 2 diabetes mellitus who have higher serum 25-hydroxyvitamin D \\[25(OH)D\\] concentrations according to the predefined study criteria. Participants in this group will undergo the same clinical and laboratory assessments, including lipid profile and glycemic measurements, for comparison with the lower vitamin D status group.",{"type":16,"investigatorFullName":17,"investigatorTitle":18,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Amany Gomaa Atiaa","lecturer","100649008","vitamin-d-status-and-lipid-profile-in-obese-adults-with-type-2-diabetes-100649008",false,"NCT07729553","Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes","Association Between Serum 25-Hydroxyvitamin D Status and Lipid Profile Among Obese Adults With Type 2 Diabetes Mellitus: A Cross-Sectional Study","VILD-T2D","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Established diagnosis of type 2 diabetes mellitus (T2DM) according to standard diagnostic criteria.\n* Obesity based on body mass index (BMI) criteria.\n* Availability of serum 25-hydroxyvitamin D \\[25(OH)D\\] measurement.\n* Availability of lipid profile and glycemic laboratory parameters.\n* Ability and willingness to provide written informed consent.\n\nExclusion Criteria:\n\n* Type 1 diabetes mellitus.\n* Pregnancy.\n* Known chronic kidney disease.\n* Chronic liver disease.\n* Active malignancy.\n* Acute infection or inflammatory disease.\n* Conditions affecting gastrointestinal absorption.\n* Use of medications or supplements that substantially alter vitamin D metabolism (when applicable).","ALL","18 Years",{"count":30,"type":31},150,"ESTIMATED","OBSERVATIONAL","This prospective, single-center, cross-sectional observational study aims to evaluate the association between serum 25-hydroxyvitamin D concentrations and lipid profile parameters among adults with obesity and established type 2 diabetes mellitus. A total of 160 participants will be recruited from an outpatient diabetes clinic in Cairo, Egypt. Each participant will undergo a single clinical, anthropometric, and laboratory assessment. No intervention or treatment will be assigned by the investigators.",[35,36,37,38],"Type 2 Diabetes Mellitus","Obesity","Dyslipidemia","Vitamin D Deficiency",[35,40,41],"Obesity; Vitamin D Deficiency; Dyslipidemia; Lipid Metabolism","Cardiometabolic Risk","NOT_YET_RECRUITING","2026-07-22",{"date":45,"type":46},"2026-07-27","ACTUAL",{"date":48,"type":31},"2026-07-25",{"date":50,"type":31},"2027-02-28",{"name":5,"class":6}]